The World Health Organization says mpox cases in the region of Congo where a new and more infectious variant was first ...

Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

Some health officials say mpox cases in Congo appear to be “stabilizing.” It's a possible sign that the epidemic for which ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Mpox, formerly known as monkeypox, drew global attention in 2022 during an outbreak that affected the U.S., Europe, Australia and many other countries. The virus comes in two distinct forms or "clades ...

The Africa Centre Disease Control (CDC), with global health partners, has announced the launch of a "pivotal" clinical trial ...

Emergent BioSolutions says its smallpox treatment to be evaluated in mpox trial in Africa. On Thursday, Emergent BioSolutions Inc. EBS stock is trading higher on mixed third-quarter earnings and a new ...

Another case of the new deadly mpox strain has been detected in the UK, health officials confirmed today. The clade 1b mutation, which experts have called 'the most dangerous one so far' kills ...

The first case of a new infectious and potentially deadly strain of mpox has been reported in the UK. The strain, known as ...

If someone suspects mpox, they should seek urgent medical advice as it is contagious. If they develop a new, unexplained skin rash, they will require prompt diagnosis and treatment to determine if ...

PANTHER to conduct clinical trial under the leadership of Africa Centres for Disease Control and PreventionGAITHERSBURG, Md., Nov. 06, 2024 ...

The first case of a new variant of mpox that has spread across the world ... Hospital High Consequence Infectious Diseases unit for treatment. Close contacts of the case are being followed up ...